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Background: Accumulation of intestinal microbial-dependent dietary phosphatidylcholine metabolite, trimethylamine N-oxide (TMAO), has been 
associated with coronary artery disease (CAD) pathogenesis. Potential pathophysiologic contributions of intestinal microflora in heart failure (HF) 
have not been described.
methods: We examined the relationship between fasting plasma TMAO and all-cause mortality over 5-year follow-up in 720 stable subjects with 
history of HF.
results: In our study cohort (mean age 66±10 years, 41% women, median BNP 294 [IQR 114-658]pg/ml), median TMAO level was 5.0 (IQR 3.0-
8.5)μM, which was higher than in the non-HF cohort (3.5 [IQR 2.3-5.7]μM, p<0.001). There was only modest correlation between TMAO and BNP 
(r=0.23, p<0.001). Higher (4th vs 1st quartile) plasma TMAO level was associated with a 3.4-fold increased mortality risk. Following adjustments 
for traditional risk factors and BNP, elevated TMAO levels remained predictive of 5-year mortality risk (Hazard ratio [HR] 2.2 [95%CI 1.42-3.43], 
p<0.001, Figure) including addition of eGFR to the model (HR 1.75 [95%CI 1.07-2.86], p<0.001).
conclusion: High TMAO levels are observed in patients with HF, and dose-dependently portend higher long-term mortality risk independent of BNP 
and renal function.
